Qube Research & Technologies LTD Vericel Corp Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Vericel Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 277,253 shares of VCEL stock, worth $9.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

277,253

Previous 263,831 5.09%

Holding current value

$9.6 Million

Previous $11.8 Million 0.21%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$37.92 - $45.7 $508,962 - $613,385	13,422 Added 5.09%	277,253 $11.8 Million
Q1 2025 May 15, 2025	BUY	$44.5 - $61.8 $3.02 Million - $4.19 Million	67,812 Added 34.59%	263,831 $11.8 Million
Q4 2024 Feb 14, 2025	SELL	$40.05 - $59.11 $352,640 - $520,463	-8,805 Reduced 4.3%	196,019 $10.8 Million
Q3 2024 Nov 14, 2024	BUY	$42.25 - $53.56 $4.27 Million - $5.41 Million	101,062 Added 97.4%	204,824 $8.65 Million
Q2 2024 Aug 14, 2024	BUY	$41.71 - $52.9 $4.33 Million - $5.49 Million	103,762 New	103,762 $4.76 Million
Q4 2023 Feb 13, 2024	BUY	$30.85 - $37.09 $1.56 Million - $1.87 Million	50,550 Added 292.94%	67,806 $2.41 Million
Q3 2023 Nov 13, 2023	BUY	$31.69 - $39.25 $546,842 - $677,298	17,256 New	17,256 $578,000
Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $533,541 - $827,367	-30,229 Reduced 69.84%	13,052 $343,000
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $444,234 - $639,053	-19,639 Reduced 31.21%	43,281 $1 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $875,983 - $1.51 Million	38,286 Added 155.42%	62,920 $1.58 Million
Q1 2022 May 09, 2022	SELL	$31.69 - $43.29 $577,740 - $789,219	-18,231 Reduced 42.53%	24,634 $942,000
Q4 2021 Feb 01, 2022	BUY	$35.2 - $52.6 $751,942 - $1.12 Million	21,362 Added 99.34%	42,865 $1.69 Million
Q3 2021 Nov 12, 2021	BUY	$46.35 - $59.75 $996,664 - $1.28 Million	21,503 New	21,503 $1.05 Million
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $254,863 - $490,115	-8,240 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$18.53 - $31.5 $383,163 - $651,357	-20,678 Reduced 71.51%	8,240 $254,000
Q3 2020 Nov 12, 2020	BUY	$14.68 - $19.12 $424,516 - $552,912	28,918 New	28,918 $536,000

Others Institutions Holding VCEL

# of Institutions

294

Shares Held

54M

Call Options Held

35.6K

Put Options Held

7.7K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $1.63B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Vericel Corp Transaction History